 Susan Apkon
Concepts (205)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscular Dystrophy, Duchenne | 20 | 2024 | 80 | 5.000 |
Why?
| | Osteoporosis | 5 | 2014 | 224 | 1.350 |
Why?
| | Spinal Muscular Atrophies of Childhood | 2 | 2018 | 14 | 1.060 |
Why?
| | Orthopedic Procedures | 2 | 2019 | 206 | 1.050 |
Why?
| | Bone Density | 6 | 2014 | 432 | 1.040 |
Why?
| | Exercise Therapy | 4 | 2019 | 351 | 0.960 |
Why?
| | Myotonic Dystrophy | 1 | 2022 | 6 | 0.780 |
Why?
| | Disabled Children | 4 | 2021 | 69 | 0.650 |
Why?
| | Morpholinos | 1 | 2019 | 29 | 0.640 |
Why?
| | Inpatients | 4 | 2016 | 378 | 0.620 |
Why?
| | Neuromuscular Diseases | 1 | 2020 | 89 | 0.610 |
Why?
| | Disease Management | 3 | 2020 | 556 | 0.590 |
Why?
| | Musculoskeletal Diseases | 1 | 2018 | 54 | 0.590 |
Why?
| | Pandemics | 3 | 2020 | 1311 | 0.580 |
Why?
| | Alaska Natives | 2 | 2016 | 116 | 0.560 |
Why?
| | Physical Therapy Modalities | 2 | 2017 | 265 | 0.550 |
Why?
| | Muscle Hypotonia | 1 | 2017 | 31 | 0.550 |
Why?
| | Child | 29 | 2022 | 18404 | 0.540 |
Why?
| | Walking | 2 | 2023 | 422 | 0.530 |
Why?
| | Rehabilitation | 1 | 2016 | 13 | 0.510 |
Why?
| | Myelitis | 1 | 2017 | 88 | 0.500 |
Why?
| | Occupational Therapy | 1 | 2017 | 74 | 0.500 |
Why?
| | Primary Health Care | 3 | 2018 | 1502 | 0.460 |
Why?
| | Muscle Spasticity | 2 | 2016 | 53 | 0.450 |
Why?
| | Recovery of Function | 6 | 2019 | 573 | 0.450 |
Why?
| | Spinal Dysraphism | 1 | 2014 | 42 | 0.440 |
Why?
| | Healthcare Disparities | 2 | 2016 | 479 | 0.440 |
Why?
| | Cerebral Palsy | 2 | 2016 | 80 | 0.430 |
Why?
| | Parents | 1 | 2021 | 1181 | 0.420 |
Why?
| | Terminal Care | 1 | 2016 | 212 | 0.410 |
Why?
| | Lumbosacral Region | 1 | 2012 | 45 | 0.410 |
Why?
| | Fractures, Bone | 2 | 2015 | 367 | 0.400 |
Why?
| | Humans | 48 | 2024 | 114049 | 0.390 |
Why?
| | Neural Tube Defects | 1 | 2012 | 59 | 0.390 |
Why?
| | Muscular Dystrophies | 2 | 2012 | 36 | 0.390 |
Why?
| | Femur | 1 | 2012 | 191 | 0.380 |
Why?
| | Critical Illness | 1 | 2016 | 640 | 0.360 |
Why?
| | Pediatrics | 1 | 2018 | 982 | 0.360 |
Why?
| | Anti-Dyskinesia Agents | 1 | 2010 | 6 | 0.350 |
Why?
| | Decision Making | 1 | 2016 | 760 | 0.330 |
Why?
| | Neuromuscular Agents | 1 | 2010 | 30 | 0.330 |
Why?
| | Botulinum Toxins | 1 | 2010 | 39 | 0.330 |
Why?
| | Brain Injuries, Traumatic | 3 | 2021 | 297 | 0.320 |
Why?
| | Diphosphonates | 2 | 2015 | 51 | 0.320 |
Why?
| | Delivery of Health Care | 2 | 2022 | 828 | 0.320 |
Why?
| | Muscular Atrophy, Spinal | 2 | 2020 | 19 | 0.320 |
Why?
| | Alendronate | 1 | 2008 | 8 | 0.300 |
Why?
| | Oligonucleotides | 2 | 2020 | 137 | 0.300 |
Why?
| | Meningomyelocele | 1 | 2008 | 54 | 0.290 |
Why?
| | Bone Density Conservation Agents | 1 | 2008 | 62 | 0.280 |
Why?
| | Down Syndrome | 1 | 2012 | 335 | 0.280 |
Why?
| | Rehabilitation Centers | 2 | 2016 | 32 | 0.250 |
Why?
| | Male | 24 | 2024 | 55398 | 0.230 |
Why?
| | Global Health | 2 | 2020 | 287 | 0.230 |
Why?
| | Prednisone | 2 | 2021 | 229 | 0.220 |
Why?
| | Child, Preschool | 12 | 2024 | 9115 | 0.220 |
Why?
| | Angelman Syndrome | 1 | 2023 | 8 | 0.210 |
Why?
| | Injections, Spinal | 2 | 2020 | 101 | 0.210 |
Why?
| | Adolescent | 13 | 2021 | 17802 | 0.200 |
Why?
| | Practice Guidelines as Topic | 3 | 2018 | 1381 | 0.200 |
Why?
| | Caregivers | 3 | 2021 | 713 | 0.200 |
Why?
| | Physical and Rehabilitation Medicine | 1 | 2022 | 28 | 0.200 |
Why?
| | Neoplasms | 1 | 2015 | 2086 | 0.200 |
Why?
| | Retrospective Studies | 11 | 2022 | 12521 | 0.190 |
Why?
| | Codon, Nonsense | 1 | 2021 | 37 | 0.190 |
Why?
| | Cone-Beam Computed Tomography | 2 | 2020 | 24 | 0.190 |
Why?
| | Comorbidity | 3 | 2020 | 1447 | 0.190 |
Why?
| | Emergency Medical Services | 2 | 2018 | 583 | 0.180 |
Why?
| | Medicine | 1 | 2022 | 102 | 0.180 |
Why?
| | Lumbar Vertebrae | 2 | 2016 | 207 | 0.180 |
Why?
| | Florida | 1 | 2021 | 73 | 0.180 |
Why?
| | Indians, North American | 2 | 2016 | 564 | 0.180 |
Why?
| | Absorptiometry, Photon | 2 | 2014 | 224 | 0.180 |
Why?
| | Schools | 2 | 2021 | 396 | 0.170 |
Why?
| | Education, Special | 1 | 2020 | 20 | 0.170 |
Why?
| | Intubation, Intratracheal | 1 | 2022 | 214 | 0.170 |
Why?
| | Female | 18 | 2024 | 59326 | 0.160 |
Why?
| | Movement | 1 | 2021 | 242 | 0.160 |
Why?
| | Orthotic Devices | 1 | 2018 | 28 | 0.160 |
Why?
| | Severity of Illness Index | 4 | 2021 | 2537 | 0.150 |
Why?
| | Endocrine System | 1 | 2018 | 19 | 0.150 |
Why?
| | Spinal Cord | 1 | 2020 | 344 | 0.150 |
Why?
| | Neuromuscular Junction | 1 | 2018 | 53 | 0.140 |
Why?
| | Behavioral Symptoms | 1 | 2018 | 41 | 0.140 |
Why?
| | Postoperative Care | 1 | 2019 | 223 | 0.140 |
Why?
| | Drug Delivery Systems | 1 | 2020 | 295 | 0.140 |
Why?
| | Quality of Life | 2 | 2018 | 2343 | 0.140 |
Why?
| | Betacoronavirus | 1 | 2020 | 247 | 0.140 |
Why?
| | Neurological Rehabilitation | 1 | 2017 | 5 | 0.140 |
Why?
| | Radiography, Interventional | 1 | 2017 | 105 | 0.140 |
Why?
| | Rhizotomy | 1 | 2016 | 3 | 0.140 |
Why?
| | Respiratory System | 1 | 2018 | 137 | 0.140 |
Why?
| | Laminectomy | 1 | 2016 | 24 | 0.130 |
Why?
| | Cardiovascular System | 1 | 2018 | 126 | 0.130 |
Why?
| | Reproducibility of Results | 2 | 2021 | 2764 | 0.130 |
Why?
| | Infant | 6 | 2024 | 7944 | 0.130 |
Why?
| | Gastrointestinal Tract | 1 | 2018 | 169 | 0.130 |
Why?
| | Follow-Up Studies | 4 | 2019 | 4392 | 0.130 |
Why?
| | Continuity of Patient Care | 1 | 2018 | 252 | 0.120 |
Why?
| | Insurance Coverage | 1 | 2017 | 199 | 0.120 |
Why?
| | Bone and Bones | 1 | 2018 | 277 | 0.120 |
Why?
| | Students | 1 | 2020 | 499 | 0.120 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 334 | 0.120 |
Why?
| | Coronavirus Infections | 1 | 2020 | 326 | 0.120 |
Why?
| | Electric Impedance | 1 | 2015 | 100 | 0.120 |
Why?
| | Infant, Newborn | 2 | 2024 | 5038 | 0.120 |
Why?
| | Range of Motion, Articular | 1 | 2017 | 350 | 0.120 |
Why?
| | Length of Stay | 2 | 2016 | 957 | 0.120 |
Why?
| | Clinical Decision-Making | 1 | 2017 | 268 | 0.120 |
Why?
| | Health Status Disparities | 1 | 2016 | 200 | 0.110 |
Why?
| | Mental Health Services | 1 | 2018 | 316 | 0.110 |
Why?
| | Wheelchairs | 2 | 2015 | 16 | 0.110 |
Why?
| | Patient Participation | 1 | 2017 | 348 | 0.110 |
Why?
| | Internship and Residency | 1 | 2022 | 920 | 0.110 |
Why?
| | Siblings | 1 | 2014 | 220 | 0.110 |
Why?
| | Minority Groups | 1 | 2015 | 223 | 0.110 |
Why?
| | Ambulatory Care | 1 | 2017 | 479 | 0.110 |
Why?
| | Self Care | 1 | 2015 | 350 | 0.100 |
Why?
| | Diagnosis, Differential | 1 | 2017 | 1331 | 0.100 |
Why?
| | Muscle Strength | 1 | 2015 | 271 | 0.100 |
Why?
| | Hospitals, Pediatric | 1 | 2016 | 478 | 0.100 |
Why?
| | Cohort Studies | 1 | 2022 | 4883 | 0.100 |
Why?
| | Risk Factors | 4 | 2015 | 8614 | 0.090 |
Why?
| | Standard of Care | 1 | 2012 | 62 | 0.090 |
Why?
| | Health Services Accessibility | 1 | 2017 | 756 | 0.090 |
Why?
| | Clinical Protocols | 1 | 2012 | 232 | 0.090 |
Why?
| | Radiography | 1 | 2012 | 803 | 0.090 |
Why?
| | Brain Injuries | 1 | 2015 | 459 | 0.090 |
Why?
| | Vitamin D | 2 | 2015 | 340 | 0.080 |
Why?
| | Thrombophilia | 1 | 2009 | 61 | 0.080 |
Why?
| | Fractures, Spontaneous | 1 | 2008 | 13 | 0.080 |
Why?
| | Sex Factors | 1 | 2014 | 1706 | 0.080 |
Why?
| | Calcium, Dietary | 1 | 2008 | 55 | 0.080 |
Why?
| | Neurologic Examination | 1 | 2008 | 113 | 0.080 |
Why?
| | Mobility Limitation | 1 | 2008 | 60 | 0.070 |
Why?
| | Hospitalization | 1 | 2016 | 1762 | 0.070 |
Why?
| | Disease Progression | 1 | 2014 | 2371 | 0.070 |
Why?
| | Calcium | 2 | 2015 | 1089 | 0.070 |
Why?
| | Adrenal Cortex Hormones | 2 | 2024 | 493 | 0.070 |
Why?
| | Brain Ischemia | 1 | 2009 | 297 | 0.070 |
Why?
| | Muscle, Skeletal | 1 | 2015 | 1468 | 0.070 |
Why?
| | Cross-Sectional Studies | 2 | 2023 | 4402 | 0.060 |
Why?
| | Torticollis | 1 | 2005 | 12 | 0.060 |
Why?
| | United States | 5 | 2022 | 12137 | 0.060 |
Why?
| | Palliative Care | 1 | 2011 | 641 | 0.060 |
Why?
| | Botulinum Toxins, Type A | 1 | 2005 | 40 | 0.060 |
Why?
| | Age Factors | 3 | 2015 | 2885 | 0.050 |
Why?
| | Risk Assessment | 3 | 2017 | 2958 | 0.050 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2011 | 1168 | 0.050 |
Why?
| | Incidence | 3 | 2015 | 2314 | 0.050 |
Why?
| | Neonatal Screening | 1 | 2024 | 151 | 0.050 |
Why?
| | Medicaid | 2 | 2017 | 404 | 0.050 |
Why?
| | Pregnenediones | 1 | 2021 | 21 | 0.050 |
Why?
| | Prednisolone | 1 | 2021 | 75 | 0.050 |
Why?
| | Treatment Adherence and Compliance | 1 | 2021 | 18 | 0.050 |
Why?
| | Young Adult | 4 | 2020 | 10446 | 0.050 |
Why?
| | Video Recording | 1 | 2021 | 141 | 0.040 |
Why?
| | Gait | 1 | 2023 | 250 | 0.040 |
Why?
| | Telephone | 1 | 2021 | 152 | 0.040 |
Why?
| | Biomechanical Phenomena | 1 | 2023 | 669 | 0.040 |
Why?
| | Knee Joint | 1 | 2023 | 322 | 0.040 |
Why?
| | Biomarkers | 1 | 2009 | 3397 | 0.040 |
Why?
| | Fluoroscopy | 1 | 2020 | 139 | 0.040 |
Why?
| | Adult | 5 | 2021 | 30377 | 0.040 |
Why?
| | Inflammation | 1 | 2009 | 2464 | 0.040 |
Why?
| | Neurosurgical Procedures | 1 | 2020 | 150 | 0.040 |
Why?
| | Education, Medical, Graduate | 1 | 2022 | 366 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2021 | 735 | 0.040 |
Why?
| | Nutrition Therapy | 1 | 2018 | 30 | 0.040 |
Why?
| | Internal Fixators | 1 | 2017 | 36 | 0.040 |
Why?
| | Pilot Projects | 1 | 2021 | 1360 | 0.030 |
Why?
| | Appointments and Schedules | 1 | 2017 | 70 | 0.030 |
Why?
| | Washington | 1 | 2017 | 134 | 0.030 |
Why?
| | Iowa | 1 | 2015 | 24 | 0.030 |
Why?
| | Myography | 1 | 2015 | 4 | 0.030 |
Why?
| | Culturally Competent Care | 1 | 2016 | 48 | 0.030 |
Why?
| | Muscle Strength Dynamometer | 1 | 2015 | 21 | 0.030 |
Why?
| | Georgia | 1 | 2015 | 62 | 0.030 |
Why?
| | Arizona | 1 | 2015 | 68 | 0.030 |
Why?
| | Prospective Studies | 2 | 2021 | 6195 | 0.030 |
Why?
| | New York | 1 | 2015 | 105 | 0.030 |
Why?
| | Efficiency, Organizational | 1 | 2016 | 126 | 0.030 |
Why?
| | Prognosis | 2 | 2014 | 3315 | 0.030 |
Why?
| | ROC Curve | 1 | 2015 | 441 | 0.030 |
Why?
| | Linear Models | 1 | 2016 | 768 | 0.030 |
Why?
| | Colorado | 2 | 2015 | 4090 | 0.030 |
Why?
| | Surveys and Questionnaires | 2 | 2017 | 4595 | 0.030 |
Why?
| | Time Factors | 2 | 2015 | 6077 | 0.030 |
Why?
| | Scoliosis | 1 | 2014 | 178 | 0.020 |
Why?
| | Cognitive Dysfunction | 1 | 2016 | 282 | 0.020 |
Why?
| | Databases, Factual | 1 | 2016 | 1125 | 0.020 |
Why?
| | Cardiomyopathies | 1 | 2014 | 298 | 0.020 |
Why?
| | Congresses as Topic | 1 | 2012 | 193 | 0.020 |
Why?
| | Health Status | 1 | 2015 | 716 | 0.020 |
Why?
| | Factor VIII | 1 | 2009 | 52 | 0.020 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2009 | 79 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2016 | 9049 | 0.020 |
Why?
| | Age of Onset | 1 | 2009 | 444 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2018 | 1815 | 0.020 |
Why?
| | Cognition | 1 | 2015 | 990 | 0.020 |
Why?
| | C-Reactive Protein | 1 | 2009 | 362 | 0.020 |
Why?
| | Middle Aged | 2 | 2020 | 26607 | 0.020 |
Why?
| | Injections, Intramuscular | 1 | 2005 | 117 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2005 | 714 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2005 | 1836 | 0.010 |
Why?
|
|
Apkon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|